-
1
-
-
0242294138
-
The impact of cytomegalovirus infection on graft function and patient outcome
-
Tolkoff-Rubin NE, Rubin RH. The impact of cytomegalovirus infection on graft function and patient outcome. Graft 1999; 2: S101-S103.
-
(1999)
Graft
, vol.2
-
-
Tolkoff-Rubin, N.E.1
Rubin, R.H.2
-
2
-
-
0032508056
-
Infection in organ-transplant recipients
-
Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338: 1741-51.
-
(1998)
N Engl J Med
, vol.338
, pp. 1741-1751
-
-
Fishman, J.A.1
Rubin, R.H.2
-
3
-
-
0033302594
-
Indirect effects of CMV in the solid organ transplant patient
-
Paya CV. Indirect effects of CMV in the solid organ transplant patient. Transpl Infect Dis 1999; 1(Suppl. 1): 8-12.
-
(1999)
Transpl Infect Dis
, vol.1
, Issue.SUPPL. 1
, pp. 8-12
-
-
Paya, C.V.1
-
4
-
-
0035428084
-
Cytomegalovirus infection in immunocompetent and immunocompromised individuals-a review
-
Vancíková Z, Dvorák P. Cytomegalovirus infection in immunocompetent and immunocompromised individuals-a review. Curr Drug Targets Immune Endocr Metabol Disord 2001; 1: 179-87.
-
(2001)
Curr Drug Targets Immune Endocr Metabol Disord
, vol.1
, pp. 179-187
-
-
Vancíková, Z.1
Dvorák, P.2
-
5
-
-
0025042563
-
Impact of cytomegalovirus infection on organ transplant recipients
-
Rubin RH. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 1990; 12(Suppl. 7): S754-S766.
-
(1990)
Rev Infect Dis
, vol.12
, Issue.SUPPL. 7
-
-
Rubin, R.H.1
-
6
-
-
0036657140
-
Cytomegalovirus infections in kidney transplant patients
-
Babel N, Kern F, Volk HD, Reinke P. Cytomegalovirus infections in kidney transplant patients. Transplant Rev 2002; 16: 121-30.
-
(2002)
Transplant Rev
, vol.16
, pp. 121-130
-
-
Babel, N.1
Kern, F.2
Volk, H.D.3
Reinke, P.4
-
7
-
-
0032573740
-
A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients
-
Flechner SM, Avery RK, Fisher R, Mastroianni BA, Papajcik DA, O'Malley KJ, et al. A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Transplantation 1998; 66: 1682-8.
-
(1998)
Transplantation
, vol.66
, pp. 1682-1688
-
-
Flechner, S.M.1
Avery, R.K.2
Fisher, R.3
Mastroianni, B.A.4
Papajcik, D.A.5
O'Malley, K.J.6
-
8
-
-
0033551348
-
Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group
-
Lowance D, Neumayer HH, Legendre CM, Squiffiet JP, Kovarik J, Brennan PJ, et al. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N Engl J Med 1999; 340: 1462-70.
-
(1999)
N Engl J Med
, vol.340
, pp. 1462-1470
-
-
Lowance, D.1
Neumayer, H.H.2
Legendre, C.M.3
Squiffiet, J.P.4
Kovarik, J.5
Brennan, P.J.6
-
9
-
-
1942469969
-
Valganciclovir Solid Organ Transplant Study Group. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients
-
Paya C, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, et al. Valganciclovir Solid Organ Transplant Study Group. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004; 4: 611-20.
-
(2004)
Am J Transplant
, vol.4
, pp. 611-620
-
-
Paya, C.1
Humar, A.2
Dominguez, E.3
Washburn, K.4
Blumberg, E.5
Alexander, B.6
-
10
-
-
33746895463
-
Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients
-
Khoury JA, Storch GA, Bohl DL, Schuessler RM, Torrence SM, Lockwood M, et al. Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients. Am J Transplant 2006; 6: 2134-43.
-
(2006)
Am J Transplant
, vol.6
, pp. 2134-2143
-
-
Khoury, J.A.1
Storch, G.A.2
Bohl, D.L.3
Schuessler, R.M.4
Torrence, S.M.5
Lockwood, M.6
-
11
-
-
0030725003
-
Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy
-
Brennan DC, Garlock KA, Lippmann BA, Buller RS, Gaudreault-Keener M, Lowell JA, et al. Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy. J Am Soc Nephrol 1997; 8: 118-25.
-
(1997)
J Am Soc Nephrol
, vol.8
, pp. 118-125
-
-
Brennan, D.C.1
Garlock, K.A.2
Lippmann, B.A.3
Buller, R.S.4
Gaudreault-Keener, M.5
Lowell, J.A.6
-
12
-
-
0034686916
-
Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants
-
Limaye AP, Corey L, Koelle DM, Davis CL, Boeckh M. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Lancet 2000; 356: 645-9.
-
(2000)
Lancet
, vol.356
, pp. 645-649
-
-
Limaye, A.P.1
Corey, L.2
Koelle, D.M.3
Davis, C.L.4
Boeckh, M.5
-
13
-
-
0035062921
-
Prophylaxis for CMV should not now replace pre-emptive therapy in solid organ transplantation
-
Emery VC. Prophylaxis for CMV should not now replace pre-emptive therapy in solid organ transplantation. Rev Med Virol 2001; 11: 83-6.
-
(2001)
Rev Med Virol
, vol.11
, pp. 83-86
-
-
Emery, V.C.1
-
14
-
-
15044349747
-
Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: A call to heed the mounting evidence
-
Singh N. Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence. Clin Infect Dis 2005; 40: 704-8.
-
(2005)
Clin Infect Dis
, vol.40
, pp. 704-708
-
-
Singh, N.1
-
15
-
-
0025891456
-
Preemptive therapy in immunocompromised hosts
-
Rubin RH. Preemptive therapy in immunocompromised hosts. N Engl J Med 1991; 324: 1057-9.
-
(1991)
N Engl J Med
, vol.324
, pp. 1057-1059
-
-
Rubin, R.H.1
-
16
-
-
0026688077
-
The TH, van der Ploeg M, van den Berg AP, Vlieger AM, van der Giessen M, van Son WJ. Direct detection of cytomegalovirus in peripheral blood leukocytes - a review of the antigenemia assay and polymerase chain reaction
-
The TH, van der Ploeg M, van den Berg AP, Vlieger AM, van der Giessen M, van Son WJ. Direct detection of cytomegalovirus in peripheral blood leukocytes - a review of the antigenemia assay and polymerase chain reaction. Transplantation 1992; 54: 193-8.
-
(1992)
Transplantation
, vol.54
, pp. 193-198
-
-
-
17
-
-
0027360379
-
Cytomegalovirus antigenemia: Clinical correlations in transplant recipients and in persons with AIDS
-
Mazzulli T, Rubin RH, Ferraro MJ, D'Aquila RT, Doveikis SA, Smith BR, et al. Cytomegalovirus antigenemia: clinical correlations in transplant recipients and in persons with AIDS. J Clin Microbiol 1993; 31: 2824-7.
-
(1993)
J Clin Microbiol
, vol.31
, pp. 2824-2827
-
-
Mazzulli, T.1
Rubin, R.H.2
Ferraro, M.J.3
D'Aquila, R.T.4
Doveikis, S.A.5
Smith, B.R.6
-
18
-
-
0031464801
-
Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation
-
Tanabe K, Tokumoto T, Ishikawa N, Koyama I, Takahashi K, Fuchinoue S, et al. Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation. Transplantation 1997; 64: 1721-5.
-
(1997)
Transplantation
, vol.64
, pp. 1721-1725
-
-
Tanabe, K.1
Tokumoto, T.2
Ishikawa, N.3
Koyama, I.4
Takahashi, K.5
Fuchinoue, S.6
-
19
-
-
0027228036
-
Early diagnosis of human cytomegalovirus disease in transplant recipients by DNA amplification in plasma
-
Wolf DG, Spector SA. Early diagnosis of human cytomegalovirus disease in transplant recipients by DNA amplification in plasma. Transplantation 1993; 56: 330-4.
-
(1993)
Transplantation
, vol.56
, pp. 330-334
-
-
Wolf, D.G.1
Spector, S.A.2
-
20
-
-
0036049260
-
Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease
-
Aranda-Verastegui F, Alberu J, Soto-Ramirez LE, Gonzalez-Aguirre H, Munoz Trejo T, Mancilla E, et al. Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease. Rev Invest Clin 2002; 54: 198-203.
-
(2002)
Rev Invest Clin
, vol.54
, pp. 198-203
-
-
Aranda-Verastegui, F.1
Alberu, J.2
Soto-Ramirez, L.E.3
Gonzalez-Aguirre, H.4
Munoz Trejo, T.5
Mancilla, E.6
-
21
-
-
0033188569
-
Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients
-
Reinke P, Prosch S, Kern F, Volk HD. Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients. Transpl Infect Dis 1999; 1: 157-64.
-
(1999)
Transpl Infect Dis
, vol.1
, pp. 157-164
-
-
Reinke, P.1
Prosch, S.2
Kern, F.3
Volk, H.D.4
-
22
-
-
0027475867
-
Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection
-
Kowalik TF, Wing B, Haskill JS, Azizkhan JC, Baldwin AS Jr, Huang ES. Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection. Proc Natl Acad Sci USA 1993; 90: 1107-11.
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 1107-1111
-
-
Kowalik, T.F.1
Wing, B.2
Haskill, J.S.3
Azizkhan, J.C.4
Baldwin Jr, A.S.5
Huang, E.S.6
-
23
-
-
0034720762
-
Rat cytomegalovirus infection in kidney allograft recipients is associated with increased expression of intracellular adhesion molecule-1 vascular adhesion molecule-1, and their ligands leukocyte function antigen-1 and very late antigen-4 in the graft
-
Kloover JS, Soots AP, Krogerus LA, Kauppinen HO, Loginov RJ, Holma KL, et al. Rat cytomegalovirus infection in kidney allograft recipients is associated with increased expression of intracellular adhesion molecule-1 vascular adhesion molecule-1, and their ligands leukocyte function antigen-1 and very late antigen-4 in the graft. Transplantation 2000; 69: 2641-7.
-
(2000)
Transplantation
, vol.69
, pp. 2641-2647
-
-
Kloover, J.S.1
Soots, A.P.2
Krogerus, L.A.3
Kauppinen, H.O.4
Loginov, R.J.5
Holma, K.L.6
-
24
-
-
0030738950
-
Cytomegalovirus infection induces anti-endothelial cell antibodies in cardiac and renal allograft recipients
-
Toyoda M, Galfayan K, Galera OA, Petrosian A, Czer LS, Jordan SC. Cytomegalovirus infection induces anti-endothelial cell antibodies in cardiac and renal allograft recipients. Transpl Immunol 1997; 5: 104-11.
-
(1997)
Transpl Immunol
, vol.5
, pp. 104-111
-
-
Toyoda, M.1
Galfayan, K.2
Galera, O.A.3
Petrosian, A.4
Czer, L.S.5
Jordan, S.C.6
-
25
-
-
3042569612
-
Cross-reactivity of cytomegalovirus-specific CD8+ T cells to allo-major histocompatibility complex class I molecules
-
Gamadia LE, Remmerswaal EB, Surachno S, Lardy NM, Wertheim-van Dillen PM, van Lier RA, et al. Cross-reactivity of cytomegalovirus-specific CD8+ T cells to allo-major histocompatibility complex class I molecules. Transplantation 2004; 77: 1879-85.
-
(2004)
Transplantation
, vol.77
, pp. 1879-1885
-
-
Gamadia, L.E.1
Remmerswaal, E.B.2
Surachno, S.3
Lardy, N.M.4
Wertheim-van Dillen, P.M.5
van Lier, R.A.6
-
26
-
-
0028151190
-
Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor
-
Fietze E, Prosch S, Reinke P, Stein J, Docke WD, Staffa G, et al. Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor. Transplantation 1994; 58: 675-80.
-
(1994)
Transplantation
, vol.58
, pp. 675-680
-
-
Fietze, E.1
Prosch, S.2
Reinke, P.3
Stein, J.4
Docke, W.D.5
Staffa, G.6
-
27
-
-
0029013575
-
Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial
-
Hibberd PL, Tolkoff-Rubin NE, Conti D, Stuart F, Thistlethwaite JR, Neylan JF, et al. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial. Ann Intern Med 1995; 123: 18-26.
-
(1995)
Ann Intern Med
, vol.123
, pp. 18-26
-
-
Hibberd, P.L.1
Tolkoff-Rubin, N.E.2
Conti, D.3
Stuart, F.4
Thistlethwaite, J.R.5
Neylan, J.F.6
-
28
-
-
0030972577
-
Long-term prognosis of renal transplantation after preemptive treatment of cytomegalovirus infection
-
Akposso K, Rondeau E, Haymann JP, Peraldi MN, Marlin C, Sraer JD. Long-term prognosis of renal transplantation after preemptive treatment of cytomegalovirus infection. Transplantation 1997; 63: 974-6.
-
(1997)
Transplantation
, vol.63
, pp. 974-976
-
-
Akposso, K.1
Rondeau, E.2
Haymann, J.P.3
Peraldi, M.N.4
Marlin, C.5
Sraer, J.D.6
-
29
-
-
3042808460
-
Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival
-
Sagedal S, Hartmann A, Nordal KP, Osnes K, Leivestad T, Foss A, et al. Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int 2004; 66: 329-37.
-
(2004)
Kidney Int
, vol.66
, pp. 329-337
-
-
Sagedal, S.1
Hartmann, A.2
Nordal, K.P.3
Osnes, K.4
Leivestad, T.5
Foss, A.6
-
30
-
-
0033611067
-
Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients
-
Humar A, Gillingham KJ, Payne WD, Dunn DL, Sutherland DE, Matas AJ. Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients. Transplantation 1999; 68: 1879-83.
-
(1999)
Transplantation
, vol.68
, pp. 1879-1883
-
-
Humar, A.1
Gillingham, K.J.2
Payne, W.D.3
Dunn, D.L.4
Sutherland, D.E.5
Matas, A.J.6
-
31
-
-
0038237028
-
Tacrolimus: A further update of its use in the management of organ transplantation
-
Scott LJ, McKeage K, Keam SJ, Plosker GL. Tacrolimus: a further update of its use in the management of organ transplantation. Drugs 2003; 63: 1247-97.
-
(2003)
Drugs
, vol.63
, pp. 1247-1297
-
-
Scott, L.J.1
McKeage, K.2
Keam, S.J.3
Plosker, G.L.4
-
32
-
-
0031001622
-
A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group
-
Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation 1997; 63: 977-83.
-
(1997)
Transplantation
, vol.63
, pp. 977-983
-
-
Pirsch, J.D.1
Miller, J.2
Deierhoi, M.H.3
Vincenti, F.4
Filo, R.S.5
|